Advantage of Microdosing GLPs
GLP-1 medications should be treated as lifelong therapies rather than stopped abruptly. Microdosing offers a sustainable alternative that maintains weight loss while reducing medication dosage. Cycling on and off GLP-1s causes progressive body composition deterioration through repeated loss of lean mass and regain of fat mass.
Summary
The transcript discusses the challenges of discontinuing GLP-1 medications and proposes microdosing as a sustainable long-term strategy. The speaker emphasizes that GLP-1s are designed to be continuous therapies rather than temporary treatments. When patients attempt to stop these medications, they face significant complications, primarily related to weight regain. The key problem with stopping GLP-1s is the unfavorable shift in body composition that occurs. When weight loss occurs on GLP-1s like semaglutide, approximately one-third of the lost weight consists of lean mass (primarily muscle with some bone loss). When patients discontinue the medication and regain weight, they regain primarily fat rather than the lost lean mass. This creates a problematic cycle: each time patients cycle on and off the medication, they lose some muscle but regain fat, progressively worsening their overall body composition with each cycle. To prevent this deterioration, the speaker recommends either adopting a microdosing approach—where patients take lower maintenance doses to keep weight stable while feeling good—or implementing a bridging plan that transitions to an alternative procedure or intervention to maintain weight loss without continued cycling. The core argument is that continuous or microdosed therapy prevents the destructive body composition shifts that occur with repeated on-off cycles.
Key Insights
- The speaker claims that approximately one-third of weight lost on GLP-1s like semaglutide is lean mass (muscle and bone), not fat.
- The speaker argues that when patients regain weight after stopping GLP-1s, they regain primarily fat rather than the lost lean mass, creating unfavorable body composition shifts.
- The speaker contends that repeated cycling on and off GLP-1s progressively worsens body composition with each cycle due to cumulative lean mass loss and fat regain.
- The speaker proposes that GLP-1 medications should be treated as lifelong medicines rather than temporary treatments to be stopped.
- The speaker recommends microdosing or bridging to alternative procedures as strategies to maintain weight loss while avoiding the destructive effects of cycling on and off medication.
Topics
Transcript
[0:00] If you stop the GLP-1s, there's problems, right? This is not meant to be stopped. These are kind of lifelong medicines. Instead of stopping it, just go to microdosing. And you'll find a spot, hopefully, you know, not everyone does, but you'll find a spot where you keep the weight off, you feel good, and you're not taking as much of the med. Now, the problem with coming off of them is, especially with the original drugs, you know, like semaglutide's an example, right, where when you lose weight, about 1/3 of the weight you lose would be lean mass, so most muscle, right, maybe some bone, et cetera. [0:32] And the problem is when you cycle on and…
Full transcript available for MurmurCast members
Sign Up to AccessMore from Andrew Huberman
Mushrooms for the Mind & Immune System | Paul Stamets
Paul Stamets discusses the therapeutic and immunological potential of fungi, including non-psychedelic mushrooms for immune enhancement and cognitive function, as well as psilocybin mushrooms for treating depression, PTSD, and OCD. He presents clinical research on mushroom extracts enhancing vaccine efficacy and explores the broader role of fungal networks in planetary health and human consciousness.
Essentials: How Emotions & Social Factors Impact Learning | Dr. Mary Helen Immordino-Yang
Dr. Mary Helen Immordino-Yang discusses how emotions, embodiment, and storytelling are fundamental to learning and human consciousness. She argues that inspiration and awe activate basic survival mechanisms through narrative meaning-making, and that current education systems suppress natural curiosity by focusing on performance metrics rather than genuine intellectual engagement and personal development.
Why Addiction is a Control Problem | Dr. Anna Lembke
Dr. Lembke argues that severe addiction is fundamentally about the desire for control rather than substance dependence. She explains that humans constantly predict outcomes in the world, and when predictions fail, they either update their mental model or attempt to control/reshape the world itself to reduce uncertainty.
Breaking the Codependency Cycle | Dr. Anna Lembke
Dr. Anna Lembke explains that when a codependent person in a family stops enabling and focuses on their own recovery through programs like Alanon, the dependent person often naturally moves toward recovery themselves. This dynamic mirrors a rope-pulling metaphor where releasing tension paradoxically resolves the stalemate.
Overcome Addictions and Obsessions of All Kinds | Dr. Anna Lembke
Dr. Anna Lembke discusses the neurobiology of addiction, emphasizing that severe addiction is fundamentally about control rather than substance use itself. She introduces the concept of 'radical surrender'—relinquishing attempts to control outcomes—as essential to recovery, and explores how spiritual practices activate different brain networks that enable escape from addictive cycles.